1. Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

   • Pamela C. Heaton

   Review Article 23 December 2012 Pages: 727 - 742

   

2. Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension

   • Michelle Orme
   • Annabel Boler

   Review Article 23 December 2012 Pages: 743 - 750

   

3. A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials

   • Darren J. Clayson
   • Diane J. Wild
   • Stephen Joel Coons

   Review Article 23 December 2012 Pages: 751 - 765

   

4. Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease

   • Virginia L. Priest
   • Evan J. Begg
   • Paul Hansen

   Original Research Article 23 December 2012 Pages: 767 - 781

   

5. A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction

   • Mark Lamotte
   • Lieven Annemans
   • York Zoellner

   Original Research Article 23 December 2012 Pages: 783 - 795

   

6. Costs of Inflammatory Bowel Disease in Germany

   • Renee Stark
   • Hans-Helmut König
   • Reiner Leidl

   Original Research Article 23 December 2012 Pages: 797 - 814

   

7. Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada

   • Michele Kohli
   • Cheryl Attard
   • Michael Marentette

   Original Research Article 23 December 2012 Pages: 815 - 830

   

8. National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget

   • Slobodan M. Jankovic
   • Nebojsa Milivojevic

   Correspondence 23 December 2012 Pages: 831 - 832